Over a quarter of hospital orders were classified as defensive

Share this content:
Over a Quarter of Hospital Orders Classified As Defensive
Over a Quarter of Hospital Orders Classified As Defensive

(HealthDay News) -- More than one-quarter of hospital medicine services were rated by ordering physicians as at least a partially defensive order, according to a research letter published online Sept. 15 in JAMA Internal Medicine.

Michael B. Rothberg, M.D., M.P.H., from the Cleveland Clinic, and colleagues estimated the cost of defensive medicine on three hospital medicine services in a health system (two community hospitals and one tertiary care hospital). Using a five-point scale, hospitalists assessed the defensiveness of their own orders (tests, procedures, or hospitalization) made the previous day.

Based on the ratings of 4,215 orders for 769 patients by 36 hospitalists, the researchers found that 28 percent of the orders were defensive. Four physicians identified no defensive orders and 21 physicians rated at least one order as mostly defensive. Physicians with ≥10 percent defensive orders placed a similar number of orders (P = 0.68) and generated similar costs per patient ($1,679 versus $1,700; P = 0.89), compared to physicians with fewer defensive orders. Roughly 13 percent of the mean cost per patient was defensive ($226 of $1,695). Orders classified as completely defensive represented 2.9 percent of costs, primarily through additional hospital days. Defensive orders were not associated with physician factors.

"Although a large portion of hospital orders had some defensive component, our study found that few orders were completely defensive and that physicians' attitudes about defensive medicine did not correlate with cost," conclude the authors.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs